Titan Pharmaceuticals Inc TTNP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:13 PM EST
3.00quote price arrow up+0.12 (+4.17%)
Volume
19,955
Close
2.88quote price arrow down-0.31 (-9.72%)
Volume
1,056,904
52 week range
2.82 - 14.06

...

Loading . . .

KEY STATS

  • Open3.15
  • Day High3.19
  • Day Low2.85
  • Prev Close3.19
  • 52 Week High14.06
  • 52 Week High Date06/10/20
  • 52 Week Low2.82
  • 52 Week Low Date11/06/20
  • Market Cap28.40M
  • Shares Out9.86M
  • 10 Day Average Volume2.55M
  • Dividend-
  • Dividend Yield-
  • Beta0.83
  • 1 Year % Change-68.17

RATIOS/PROFITABILITY

  • EPS (TTM)-7.39
  • P/E (TTM)-0.39
  • Fwd P/E (NTM)-0.66
  • EBITDA (MRQ)-16.793M
  • ROE (MRQ)-3,431.55%
  • Revenue (MRQ)5.00M
  • Gross Margin (MRQ)67.35%
  • Net Margin (MRQ)-382.11%
  • Debt To Equity (MRQ)-570.79%

EVENTS

  • Earnings Date03/31/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Titan Pharmaceuticals Inc News

There is no recent news for this security.

Latest TTNP News From Our Partners

QUOTE FINDER

Profile

MORE
Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's...
Marc Rubin M.D.
Chairman
Katherine DeVarney Ph.D.
President
Address
400 Oyster Point Blvd Ste 505
South San Francisco, CA
94080-1958
United States